comparemela.com

Latest Breaking News On - China life sciences - Page 1 : comparemela.com

New findings expand the genotypic spectrum of NPRL3-associated focal epilepsy

Science China Life Sciences magazine recently reported on the research results of Tang Beisha's team from Xiangya Hospital of Central South University, Liu Jing Yu's team from the Institute of Neurology of the Chinese Academy of Sciences, and Zhang Luoying's team from Huazhong University of Science and Technology, including Du Shiyue, Zeng Sheng, and Song Li. Epilepsy has a complex etiology with 80% owing a genetic basis.

Functional characterization of novel NPRL3 mutations identified in three families with focal epilepsy

Functional characterization of novel NPRL3 mutations identified in three families with focal epilepsy
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Goodwin Recognized as a Leading Firm in Asia Across Private Equity, Private Investment Funds, M&A and Life Sciences | News & Events

Ropes & Gray Advises Everest Medicines on Agreement with Gilead Sciences for Cancer Drug Trodelvy in Asia Territories

Everest Medicines, advised by Ropes & Gray, announced on Aug. 16, 2022, that it has entered into an agreement with Immunomedics, Inc. under which Immunomedics will obtain exclusive rights to develop and commercialize cancer drug Trodelvy in Asia territories.

China s Future of Health: Empowering consumers through cross-sector collaboration and innovation key to systemic transformation

China s Future of Health: Empowering consumers through cross-sector collaboration and innovation key to systemic transformation
harbourtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from harbourtimes.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.